skip to content

Roche to present data on TECENTRIQ (Atezolizumab) and data from across its cancer immunotherapy portfolio at the 2018 American Association of Cancer Research (AACR) Annual Meeting

Investors

Investor updates
view all

stay updated

get the latest news and updates to your inbox.